Regional abdominal hyperthermia combined with systemic chemotherapy for the treatment of patients with ovarian cancer relapse: Results of a pilot study
/in Hyperthermia, International Publications, Ovarian CancerCellular immunotherapy for ovarian cancer
/in Dendritic Cells, International Publications, Ovarian CancerWhole-body hyperthermia (WBH) in combination with carboplatin in patients with recurrent ovarian cancer – a phase II study
/in Hyperthermia, International Publications, Ovarian CancerOvarian cancer detection and treatment: current situation and future prospects
/in International Publications, Ovarian CancerImmunotherapy opportunities in ovarian cancer
/in Dendritic Cells, International Publications, Ovarian CancerVaccination with dendritic cells transfected with mRNA-encoded folate-receptor-alpha for relapsed metastatic ovarian cancer
/in International Publications, Ovarian CancerIn vitro assessment of dendritic cells pulsed with apoptotic tumor cells as a vaccine for ovarian cancer patients
/in Dendritic Cells, International Publications, Ovarian CancerPreparation of apoptotic tumor cells with replication-incompetent HSV augments the efficacy of dendritic cell vaccines
/in International Publications, Ovarian Cancer
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer